v3.26.1
Condensed Consolidated Statements of Stockholders' (Deficit) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated deficit [Member]
Balance at Dec. 31, 2024 $ (24,335) $ 3 $ 270,247 $ (294,585)
Balance, shares at Dec. 31, 2024   321,252    
Vesting of restricted stock units, shares   3,750    
Stock-based compensation expense 20   20  
Net Income (Loss) (1,709)     (1,709)
Balance at Mar. 31, 2025 (26,024) $ 3 270,267 (296,294)
Balance, shares at Mar. 31, 2025   325,002    
Balance at Dec. 31, 2024 (24,335) $ 3 270,247 (294,585)
Balance, shares at Dec. 31, 2024   321,252    
Exercise of pre-funded warrants 0      
Net Income (Loss) (3,600)      
Balance at Jun. 30, 2025 (27,899) $ 3 270,283 (298,185)
Balance, shares at Jun. 30, 2025   325,002    
Balance at Mar. 31, 2025 (26,024) $ 3 270,267 (296,294)
Balance, shares at Mar. 31, 2025   325,002    
Stock-based compensation expense 16   16  
Net Income (Loss) (1,891)     (1,891)
Balance at Jun. 30, 2025 (27,899) $ 3 270,283 (298,185)
Balance, shares at Jun. 30, 2025   325,002    
Balance at Dec. 31, 2025 $ (11,907) $ 4 288,669 (300,580)
Balance, shares at Dec. 31, 2025 435,432 435,432    
Issuance of pre-funded warrants under the Coastlands and Domicilium Securities Purchase Agreements, net of issuance costs of $9k $ 6,991   6,991  
Issuance of pre-funded warrants related to the February 2026 Domicilium debt conversion 1,000   1,000  
Exercise of stock options 40 $ 1 39  
Exercise of stock options, shares   23,723    
Vesting of restricted stock units, shares   1,977    
Stock-based compensation expense 46   46  
Net Income (Loss) (3,754)     (3,754)
Balance at Mar. 31, 2026 (7,584) $ 5 296,745 (304,334)
Balance, shares at Mar. 31, 2026   461,132    
Balance at Dec. 31, 2025 $ (11,907) $ 4 288,669 (300,580)
Balance, shares at Dec. 31, 2025 435,432 435,432    
Exercise of stock options, shares 23,723      
Exercise of pre-funded warrants $ 91      
Net Income (Loss) (8,256)      
Balance at Jun. 30, 2026 $ 46,420 $ 40 355,216 (308,836)
Balance, shares at Jun. 30, 2026 4,036,398 4,036,398    
Balance at Mar. 31, 2026 $ (7,584) $ 5 296,745 (304,334)
Balance, shares at Mar. 31, 2026   461,132    
Issuance of common stock and pre-funded warrants in connection with June 2026 public offering, net of issuance costs 58,320 $ 29 58,291 0
Issuance of common stock and pre-funded warrants in connection with June 2026 public offering, net of issuance costs. Shares   2,975,000    
Exercise of pre-funded warrants, shares   600,000    
Exercise of pre-funded warrants 91 $ 6 85  
Effect due to reverse stock split, shares   (6)    
Vesting of restricted stock awards shares   272    
Stock-based compensation expense 95   95  
Net Income (Loss) (4,502)     (4,502)
Balance at Jun. 30, 2026 $ 46,420 $ 40 $ 355,216 $ (308,836)
Balance, shares at Jun. 30, 2026 4,036,398 4,036,398